U.S. Hemostasis Valve Market Size & Trends
The U.S. hemostasis valve market size was estimated at USD 64.47 million in 2024 and is projected to grow at a CAGR of 5.4% from 2025 to 2033.The market is experiencing significant growth due to several key factors, including the rising incidence of cardiovascular diseases, favorable regulatory support, an aging population, and ongoing technological advancements. A notable driver is the increasing preference for minimally invasive procedures, which offer advantages such as less pain, shorter hospital stays, quicker recovery, and a reduced risk of complications compared to traditional open surgeries.This shift is fueling the demand for medical devices that support these techniques. Hemostasis valves play a critical role in minimally invasive catheter-based procedures by ensuring controlled blood flow and preventing leakage during interventions.
Air pollution is increasingly recognized as a major contributor to the rise in cardiovascular diseases. Both chronic and short-term exposures significantly raise the risk of cardiovascular emergencies and mortality in the U.S. The World Heart Report 2024 highlights that air pollution worsens all major cardiovascular diseases (CVDs). In 2019, nearly 70% of the 4.2 million deaths linked to ambient air pollution were due to cardiovascular issues, particularly ischemic heart disease (1.9 million deaths) and stroke (900,000 deaths). As a result, there is an increased need for diagnostic and therapeutic procedures such as angiography and angioplasty, where hemostasis valves play a crucial role in maintaining patient safety by regulating blood flow during catheter-based interventions.
Technological advancements in medical devices are pivotal in driving the market growth. Ongoing technological advancements are playing a key role in improving the performance and reliability of hemostasis valves. Manufacturers are continuously innovating to enhance valve design, material quality, and compatibility with a variety of catheter sizes and interventional tools. These improvements help reduce the risk of blood leakage, improve ease of use for clinicians, and enhance patient safety during minimally invasive procedures. For example, Merit Medical Systems offers advanced hemostasis valves such as the Merit AccessPLUS and Honor Hemostasis Valves, which are designed with ergonomic features, superior sealing mechanisms, and robust hemostatic control. These innovations reflect the industry's focus on optimizing procedural efficiency and reducing complications in catheter-based interventions.
U.S. Hemostasis Valve Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. hemostasis valve market report based on type, application, and end use:Type Outlook (Revenue, USD Million, 2021 - 2033)
- Hemostasis Valve Y- Connectors
- Double Y- Y-Connector Hemostasis Valves
- One-Handed Hemostasis Valves
- Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
- Angiography
- Angioplasty
End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Hemostasis Valve Market Variables, Trends & Scope
Chapter 4. U.S. Hemostasis Valve Market: Type Estimates & Trend Analysis
Chapter 5. U.S. Hemostasis Valve Market: Application Estimates & Trend Analysis
Chapter 6. U.S. Hemostasis Valve Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Boston Scientific Corporation
- Teleflex Incorporated
- Merit Medical Systems
- B. Braun Melsungen AG
- TERUMO CORPORATION
- Abbott
- Argon Medical Devices
- Freudenberg Medical
- DeRoyal Industries, Inc.
- Antmed Corporation